This evaluation focused on the technological innovation and commercialization potential of startup items. HADD Science was recognized for the excellence of its independently developed unique biomaterial technology and 3D cell culture platform technology. CEO Heo Chae-jeong stated the company's goal to grow into a leading enterprise in the global bio market.
